Skip Content
You are currently on the new version of our website. Access the old version .

Cancers, Volume 11, Issue 9

2019 September - 188 articles

Cover Story: A better knowledge of the immunology of T-cell activation has led to the establishment of immune checkpoint inhibition (ICI) using monoclonal antibodies to block the inhibition of T-cell activation through PD1: PDL1 and CTLA-4: B7 interactions. Both VEGF-inhibition and ICI allow durable responses and increase the survival rate of patients suffering this dreadful disease. New combination therapies such as pembrolizumab plus axitinib or ipilimumab plus nivolumab have emerged and rapidly reached the category of first-line options, while more classical treatments based on VEGF-inhibition alone, for example, sunitinib, pazopanib, or cabozantinib, remain excellent alternatives. However, many questions are still unanswered in this new therapeutic landscape, including how to minimize treatment toxicities, find optimal markers of response, and solve the dilemma on the role of cytoreductive nephrectomy in these patients. View this paper
  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
  • You may sign up for email alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.

Articles (188)

  • Review
  • Open Access
18 Citations
5,951 Views
19 Pages

Dendritic Cell-Based and Other Vaccination Strategies for Pediatric Cancer

  • Sévérine de Bruijn,
  • Sébastien Anguille,
  • Joris Verlooy,
  • Evelien L. Smits,
  • Viggo F. van Tendeloo,
  • Maxime de Laere,
  • Koenraad Norga,
  • Zwi N. Berneman and
  • Eva Lion

19 September 2019

Dendritic cell-based and other vaccination strategies that use the patient’s own immune system for the treatment of cancer are gaining momentum. Most studies of therapeutic cancer vaccination have been performed in adults. However, since cancer...

  • Article
  • Open Access
18 Citations
6,689 Views
19 Pages

γ-H2AX Foci Persistence at Chromosome Break Suggests Slow and Faithful Repair Phases Restoring Chromosome Integrity

  • Michelle Ricoul,
  • Tamizh Selvan Gnana Sekaran,
  • Patricia Brochard,
  • Cecile Herate and
  • Laure Sabatier

19 September 2019

Many toxic agents can cause DNA double strand breaks (DSBs), which are in most cases quickly repaired by the cellular machinery. Using ionising radiation, we explored the kinetics of DNA lesion signaling and structural chromosome aberration formation...

  • Article
  • Open Access
72 Citations
5,482 Views
13 Pages

CD8+ and Regulatory T cells Differentiate Tumor Immune Phenotypes and Predict Survival in Locally Advanced Head and Neck Cancer

  • Alessia Echarti,
  • Markus Hecht,
  • Maike Büttner-Herold,
  • Marlen Haderlein,
  • Arndt Hartmann,
  • Rainer Fietkau and
  • Luitpold Distel

19 September 2019

Background: The tumor immune status “inflamed”, “immune excluded”, and “desert” might serve as a predictive parameter. We studied these three cancer immune phenotypes while using a simple immunohistochemical algori...

  • Article
  • Open Access
43 Citations
7,682 Views
16 Pages

Matched Whole-Genome Sequencing (WGS) and Whole-Exome Sequencing (WES) of Tumor Tissue with Circulating Tumor DNA (ctDNA) Analysis: Complementary Modalities in Clinical Practice

  • Robin Imperial,
  • Marjan Nazer,
  • Zaheer Ahmed,
  • Audrey E. Kam,
  • Timothy J. Pluard,
  • Waled Bahaj,
  • Mia Levy,
  • Timothy M. Kuzel,
  • Dana M. Hayden and
  • Ashiq Masood
  • + 2 authors

19 September 2019

Tumor heterogeneity, especially intratumoral heterogeneity, is a primary reason for treatment failure. A single biopsy may not reflect the complete genomic architecture of the tumor needed to make therapeutic decisions. Circulating tumor DNA (ctDNA)...

  • Article
  • Open Access
54 Citations
8,167 Views
18 Pages

Blockade of PD-L1 Enhances Cancer Immunotherapy by Regulating Dendritic Cell Maturation and Macrophage Polarization

  • Nai-Yun Sun,
  • Yu-Li Chen,
  • Wen-Yih Wu,
  • Han-Wei Lin,
  • Ying-Cheng Chiang,
  • Chi-Fang Chang,
  • Yi-Jou Tai,
  • Heng-Cheng Hsu,
  • Chi-An Chen and
  • Wen-Fang Cheng
  • + 1 author

19 September 2019

The immuno-inhibitory checkpoint PD-L1, regulated by tumor cells and antigen-presenting cells (APCs), dampened the activation of T cells from the PD-1/PD-L1 axis. PD-L1-expressing APCs rather than tumor cells demonstrated the essential anti-tumor eff...

  • Review
  • Open Access
93 Citations
7,120 Views
18 Pages

19 September 2019

The characterization of tumor biology and consequently the identification of prognostic and predictive biomarkers represent key issues for the translational research in breast cancer (BC). Phosphatase and tensin homolog deleted on chromosome ten (PTE...

  • Review
  • Open Access
119 Citations
17,612 Views
23 Pages

19 September 2019

Cancer and diabetes are amongst the leading causes of deaths worldwide. There is an alarming rise in cancer incidences and mortality, with approximately 18.1 million new cases and 9.6 million deaths in 2018. A major contributory but neglected factor...

  • Article
  • Open Access
14 Citations
4,984 Views
19 Pages

Hypoxia Downregulates LPP3 and Promotes the Spatial Segregation of ATX and LPP1 During Cancer Cell Invasion

  • Kelly Harper,
  • Karine Brochu-Gaudreau,
  • Caroline Saucier and
  • Claire M. Dubois

19 September 2019

Hypoxia is a common characteristic of advanced solid tumors and a potent driver of tumor invasion and metastasis. Recent evidence suggests the involvement of autotaxin (ATX) and lysophosphatidic acid receptors (LPARs) in cancer cell invasion promoted...

  • Article
  • Open Access
19 Citations
4,345 Views
13 Pages

Prognostic Factors for Event-Free Survival in Pediatric Patients with Hepatoblastoma Based on the 2017 PRETEXT and CHIC-HS Systems

  • Hee Mang Yoon,
  • Jisun Hwang,
  • Kyung Won Kim,
  • Jung-Man Namgoong,
  • Dae Yeon Kim,
  • Kyung-Nam Koh,
  • Hyery Kim and
  • Young Ah Cho

18 September 2019

This study aimed to evaluate the prognostic value of variables used in the 2017 PRE-Treatment EXTent of tumor (PRETEXT) system and the Children’s Hepatic tumors International Collaboration-Hepatoblastoma Stratification (CHIC-HS) system in pedia...

  • Review
  • Open Access
86 Citations
7,810 Views
14 Pages

BRAF Inhibitors in Thyroid Cancer: Clinical Impact, Mechanisms of Resistance and Future Perspectives

  • Fabiana Crispo,
  • Tiziana Notarangelo,
  • Michele Pietrafesa,
  • Giacomo Lettini,
  • Giovanni Storto,
  • Alessandro Sgambato,
  • Francesca Maddalena and
  • Matteo Landriscina

18 September 2019

The Kirsten rat sarcoma viral oncogene homolog (RAS)/v-raf-1 murine leukemia viral oncogene homolog 1 (RAF)/mitogen-activated protein kinase 1 (MAPK) signaling cascade is the most important oncogenic pathway in human cancers. Tumors leading mutations...

  • Review
  • Open Access
56 Citations
8,299 Views
29 Pages

18 September 2019

Ovarian cancer is a serious cause of death in gynecological oncology. Delayed diagnosis and poor survival rates associated with late stages of the disease are major obstacles against treatment efforts. Heat shock proteins (HSPs) are stress responsive...

  • Article
  • Open Access
49 Citations
5,898 Views
13 Pages

18 September 2019

Toxicity and the development of resistance by cancer cells are impediments for docetaxel (DTX), a primary drug for treating prostate cancer (PCa). Since the combination of DTX with natural compounds can increase its effectiveness by reducing its toxi...

  • Article
  • Open Access
6 Citations
4,151 Views
17 Pages

TWIST1 Heterodimerization with E12 Requires Coordinated Protein Phosphorylation to Regulate Periostin Expression

  • Svetlana A. Mikheeva,
  • Nathan D. Camp,
  • Lei Huang,
  • Antrix Jain,
  • Sung Yun Jung,
  • Naze G. Avci,
  • Mari Tokita,
  • Alejandro Wolf-Yadlin,
  • Jing Zhang and
  • Andrei M. Mikheev
  • + 2 authors

18 September 2019

Diffuse invasion into adjacent brain matter by glioblastoma (GBM) is largely responsible for their dismal prognosis. Previously, we showed that the TWIST1 (TW) bHLH transcription factor and its regulated gene periostin (POSTN) promote invasive phenot...

  • Article
  • Open Access
18 Citations
5,257 Views
17 Pages

Should Tumor Infiltrating Lymphocytes, Androgen Receptor, and FOXA1 Expression Predict the Clinical Outcome in Triple Negative Breast Cancer Patients?

  • Anita Mangia,
  • Concetta Saponaro,
  • Alessandro Vagheggini,
  • Giuseppina Opinto,
  • Matteo Centonze,
  • Chiara Vicenti,
  • Ondina Popescu,
  • Maria Pastena,
  • Francesco Giotta and
  • Nicola Silvestris

18 September 2019

Tumor-infiltrating lymphocytes (TILs) are a valuable indicator of the immune microenvironment that plays the central role in new anticancer drugs. TILs have a strong prognostic role in triple negative breast cancer (TNBC). Little is known about the i...

  • Article
  • Open Access
23 Citations
5,238 Views
24 Pages

18 September 2019

Specific kinds of interleukin (IL) receptors are known to mediate lymphocyte proliferation and survival. However, recent reports have suggested that the high expression of IL4Rα and IL13Rα1 in tumor tissue might be associated with tumorigenesis in se...

  • Feature Paper
  • Review
  • Open Access
27 Citations
7,895 Views
21 Pages

Management of Small Bowel Neuroendocrine Tumors

  • Vincent Larouche,
  • Amit Akirov,
  • Sameerah Alshehri and
  • Shereen Ezzat

18 September 2019

Several important landmark trials have reshaped the landscape of non-surgical management of small bowel neuroendocrine tumors over the last few years, with the confirmation of the antitumor effect of somatostatin analogue therapy in PROMID and CLARIN...

  • Review
  • Open Access
11 Citations
3,497 Views
24 Pages

17 September 2019

Isolated pancreas metastases are a rare type of metastasis of renal cell carcinoma, characterized by the presence of pancreatic metastases, while all other organs remain unaffected. In a previous study, we determined arguments from the literature whi...

  • Feature Paper
  • Article
  • Open Access
20 Citations
4,226 Views
19 Pages

Age-Related Alterations in Immune Contexture Are Associated with Aggressiveness in Rhabdomyosarcoma

  • Patrizia Gasparini,
  • Orazio Fortunato,
  • Loris De Cecco,
  • Michela Casanova,
  • Maria Federica Iannó,
  • Andrea Carenzo,
  • Giovanni Centonze,
  • Massimo Milione,
  • Paola Collini and
  • Andrea Ferrari
  • + 10 authors

17 September 2019

Adolescents and young adults (AYA) with rhabdomyosarcoma (RMS) form a subgroup of patients whose optimal clinical management and access to care remain a challenge and whose survival lacks behind that of children diagnosed with histologically similar...

  • Article
  • Open Access
57 Citations
12,361 Views
13 Pages

BRAF Mutations Classes I, II, and III in NSCLC Patients Included in the SLLIP Trial: The Need for a New Pre-Clinical Treatment Rationale

  • Jillian Wilhelmina Paulina Bracht,
  • Niki Karachaliou,
  • Trever Bivona,
  • Richard B. Lanman,
  • Iris Faull,
  • Rebecca J. Nagy,
  • Ana Drozdowskyj,
  • Jordi Berenguer,
  • Manuel Fernandez-Bruno and
  • Rafael Rosell
  • + 1 author

17 September 2019

BRAF V600 mutations have been found in 1–2% of non-small-cell lung cancer (NSCLC) patients, with Food and Drug Administration (FDA) approved treatment of dabrafenib plus trametinib and progression free survival (PFS) of 10.9 months. However, 50...

  • Review
  • Open Access
136 Citations
14,387 Views
15 Pages

Radioiodine-Refractory Thyroid Cancer: Molecular Basis of Redifferentiation Therapies, Management, and Novel Therapies

  • Mohamed Aashiq,
  • Deborah A. Silverman,
  • Shorook Na’ara,
  • Hideaki Takahashi and
  • Moran Amit

17 September 2019

Recurrent, metastatic disease represents the most frequent cause of death for patients with thyroid cancer, and radioactive iodine (RAI) remains a mainstay of therapy for these patients. Unfortunately, many thyroid cancer patients have tumors that no...

  • Article
  • Open Access
16 Citations
3,941 Views
14 Pages

Encapsulated Carbenoxolone Reduces Lung Metastases

  • Adi Karsch-Bluman,
  • Shimrit Avraham,
  • Miri Assayag,
  • Ouri Schwob and
  • Ofra Benny

17 September 2019

Carbenoxolone is an anti-inflammatory compound and a derivate of a natural substance from the licorice plant. We previously showed that carbenoxolone reduces the metastatic burden in the lungs of mice through its antagonistic effect on high mobility...

  • Article
  • Open Access
13 Citations
3,992 Views
12 Pages

17 September 2019

Yatein is an antitumor agent isolated from Calocedrus formosana Florin leaves extract. In our previous study, we found that yatein inhibited the growth of human lung adenocarcinoma A549 and CL1-5 cells by inducing intrinsic and extrinsic apoptotic pa...

  • Article
  • Open Access
29 Citations
4,259 Views
15 Pages

XIST-Promoter Demethylation as Tissue Biomarker for Testicular Germ Cell Tumors and Spermatogenesis Quality

  • João Lobo,
  • Sandra P. Nunes,
  • Ad J. M. Gillis,
  • Daniela Barros-Silva,
  • Vera Miranda-Gonçalves,
  • Annette van den Berg,
  • Mariana Cantante,
  • Rita Guimarães,
  • Rui Henrique and
  • Leendert H. J. Looijenga
  • + 1 author

17 September 2019

Background: The event of X chromosome inactivation induced by XIST, which is physiologically observed in females, is retained in testicular germ cell tumors (TGCTs), as a result of a supernumerary X chromosome constitution. X chromosome inactivation...

  • Article
  • Open Access
55 Citations
7,486 Views
15 Pages

Targeting Pyruvate Kinase M2 and Lactate Dehydrogenase A Is an Effective Combination Strategy for the Treatment of Pancreatic Cancer

  • Goran Hamid Mohammad,
  • Vessela Vassileva,
  • Pilar Acedo,
  • Steven W. M. Olde Damink,
  • Massimo Malago,
  • Dipok Kumar Dhar and
  • Stephen P. Pereira

16 September 2019

Reprogrammed glucose metabolism is one of the hallmarks of cancer, and increased expression of key glycolytic enzymes, such as pyruvate kinase M2 (PKM2) and lactate dehydrogenase A (LDHA), has been associated with poor prognosis in various malignanci...

  • Article
  • Open Access
18 Citations
4,597 Views
18 Pages

Cytotoxicity and Differentiating Effect of the Poly(ADP-Ribose) Polymerase Inhibitor Olaparib in Myelodysplastic Syndromes

  • Isabella Faraoni,
  • Maria Irno Consalvo,
  • Francesca Aloisio,
  • Emiliano Fabiani,
  • Manuela Giansanti,
  • Francesca Di Cristino,
  • Giulia Falconi,
  • Lucio Tentori,
  • Ambra Di Veroli and
  • Maria Teresa Voso
  • + 5 authors

16 September 2019

Myelodysplastic syndromes (MDS) are highly heterogeneous myeloid diseases, characterized by frequent genetic/chromosomal aberrations. Olaparib is a potent, orally bioavailable poly(ADP-ribose) polymerase 1 (PARP1) inhibitor with acceptable toxicity p...

  • Review
  • Open Access
72 Citations
10,740 Views
24 Pages

Targeting Autophagy for Overcoming Resistance to Anti-EGFR Treatments

  • Yoojung Kwon,
  • Misun Kim,
  • Hyun Suk Jung,
  • Youngmi Kim and
  • Dooil Jeoung

16 September 2019

Epidermal growth factor receptor (EGFR) plays critical roles in cell proliferation, tumorigenesis, and anti-cancer drug resistance. Overexpression and somatic mutations of EGFR result in enhanced cancer cell survival. Therefore, EGFR can be a target...

  • Feature Paper
  • Review
  • Open Access
89 Citations
20,786 Views
15 Pages

The Immune Microenvironment of Breast Cancer Progression

  • Helen Tower,
  • Meagan Ruppert and
  • Kara Britt

16 September 2019

Inflammation is now recognized as a hallmark of cancer. Genetic changes in the cancer cell are accepted as the match that lights the fire, whilst inflammation is seen as the fuel that feeds the fire. Once inside the tumour, the immune cells secrete c...

  • Article
  • Open Access
18 Citations
3,915 Views
9 Pages

Impact of Surgery on Long-Term Results of Hearing in Neurofibromatosis Type-2 Associated Vestibular Schwannomas

  • Isabel Gugel,
  • Florian Grimm,
  • Marina Liebsch,
  • Julian Zipfel,
  • Christian Teuber,
  • Lan Kluwe,
  • Victor-Felix Mautner,
  • Marcos Tatagiba and
  • Martin Ulrich Schuhmann

16 September 2019

Hearing preservation is a major goal in the treatment of neurofibromatosis type 2 (NF2) associated vestibular schwannoma (VS), particularly in children and adolescents. In this study, we retrospectively reviewed hearing and volumetry data sets of 39...

  • Article
  • Open Access
28 Citations
5,560 Views
11 Pages

MALDI-MSI as a Complementary Diagnostic Tool in Cytopathology: A Pilot Study for the Characterization of Thyroid Nodules

  • Giulia Capitoli,
  • Isabella Piga,
  • Stefania Galimberti,
  • Davide Leni,
  • Angela Ida Pincelli,
  • Mattia Garancini,
  • Francesca Clerici,
  • Allia Mahajneh,
  • Virginia Brambilla and
  • Fabio Pagni
  • + 2 authors

16 September 2019

The present study applies for the first time as Matrix-Assisted Laser Desorption/Ionization (MALDI) Mass Spectrometry Imaging (MSI) on real thyroid Fine Needle Aspirations (FNAs) to test its possible complementary role in routine cytology in the diag...

  • Article
  • Open Access
33 Citations
4,724 Views
14 Pages

CYP17A1 Maintains the Survival of Glioblastomas by Regulating SAR1-Mediated Endoplasmic Reticulum Health and Redox Homeostasis

  • Hong-Yi Lin,
  • Chiung-Yuan Ko,
  • Tzu-Jen Kao,
  • Wen-Bin Yang,
  • Yu-Ting Tsai,
  • Jian-Ying Chuang,
  • Siou-Lian Hu,
  • Pei-Yu Yang,
  • Wei-Lun Lo and
  • Tsung-I Hsu

16 September 2019

Cytochrome P450 (CYP) 17A1 is an important steroidogenic enzyme harboring 17α-hydroxylase and performing 17,20 lyase activities in multiple steps of steroid hormone synthesis, including dehydroepiandrosterone (DHEA) biosynthesis. Previously, we...

  • Article
  • Open Access
108 Citations
12,202 Views
16 Pages

Hyperspectral Imaging of Head and Neck Squamous Cell Carcinoma for Cancer Margin Detection in Surgical Specimens from 102 Patients Using Deep Learning

  • Martin Halicek,
  • James D. Dormer,
  • James V. Little,
  • Amy Y. Chen,
  • Larry Myers,
  • Baran D. Sumer and
  • Baowei Fei

14 September 2019

Surgical resection of head and neck (H and N) squamous cell carcinoma (SCC) may yield inadequate surgical cancer margins in 10 to 20% of cases. This study investigates the performance of label-free, reflectance-based hyperspectral imaging (HSI) and a...

  • Review
  • Open Access
57 Citations
7,663 Views
19 Pages

14 September 2019

The adenoma-to-carcinoma progression in colon cancer is driven by a sequential accumulation of genetic alterations at specific tumor suppressors and oncogenes. In contrast, the multistage route from the primary site to metastasis formation is underli...

  • Review
  • Open Access
11 Citations
3,956 Views
14 Pages

14 September 2019

The revelation that microRNAs (miRNAs) exist within the human genome uncovered an underappreciated mechanism of gene expression. For cells to regulate expression of their genes, miRNA molecules and argonaute proteins bind to mRNAs and interfere with...

  • Review
  • Open Access
22 Citations
4,691 Views
16 Pages

Direct Intercellular Communications and Cancer: A Snapshot of the Biological Roles of Connexins in Prostate Cancer

  • Catalina Asencio-Barría,
  • Norah Defamie,
  • Juan C. Sáez,
  • Marc Mesnil and
  • Alejandro S. Godoy

14 September 2019

Tissue homeostasis is the result of a complex intercellular network controlling the behavior of every cell for the survival of the whole organism. In mammalian tissues, cells do communicate via diverse long- and short-range communication mechanisms....

  • Article
  • Open Access
47 Citations
6,350 Views
16 Pages

Bispecific GRPR-Antagonistic Anti-PSMA/GRPR Heterodimer for PET and SPECT Diagnostic Imaging of Prostate Cancer

  • Bogdan Mitran,
  • Zohreh Varasteh,
  • Ayman Abouzayed,
  • Sara S. Rinne,
  • Emmi Puuvuori,
  • Maria De Rosa,
  • Mats Larhed,
  • Vladimir Tolmachev,
  • Anna Orlova and
  • Ulrika Rosenström

14 September 2019

Simultaneous targeting of the prostate-specific membrane antigen (PSMA) and gastrin-releasing peptide receptor (GRPR) could improve the diagnostic accuracy in prostate cancer (PCa). The aim of this study was to develop a PSMA/GRPR-targeting bispecifi...

  • Article
  • Open Access
19 Citations
4,888 Views
10 Pages

Diffuse Lung Metastases in EGFR-Mutant Non-Small Cell Lung Cancer

  • Subba R. Digumarthy,
  • Dexter P. Mendoza,
  • Atul Padole,
  • Tianqi Chen,
  • P. Gabriel Peterson,
  • Zofia Piotrowska and
  • Lecia V. Sequist

13 September 2019

Diffuse lung metastases have been reported in non-small cell lung cancer (NSCLC) harboring epidermal growth factor receptor (EGFR) mutations. The purpose of our study was to compare the incidence of diffuse lung metastases in EGFR-mutant NSCLC and EG...

  • Article
  • Open Access
29 Citations
5,896 Views
17 Pages

Allosteric AKT Inhibitors Target Synthetic Lethal Vulnerabilities in E-Cadherin-Deficient Cells

  • Nicola Bougen-Zhukov,
  • Yasmin Nouri,
  • Tanis Godwin,
  • Megan Taylor,
  • Christopher Hakkaart,
  • Andrew Single,
  • Tom Brew,
  • Elizabeth Permina,
  • Augustine Chen and
  • Parry Guilford
  • + 1 author

13 September 2019

The CDH1 gene, encoding the cell adhesion protein E-cadherin, is one of the most frequently mutated genes in gastric cancer and inactivating germline CDH1 mutations are responsible for hereditary diffuse gastric cancer syndrome (HDGC). Using cell via...

  • Article
  • Open Access
5 Citations
4,543 Views
16 Pages

In Silico Drug Prescription for Targeting Cancer Patient Heterogeneity and Prediction of Clinical Outcome

  • Elena Piñeiro-Yáñez,
  • María José Jiménez-Santos,
  • Gonzalo Gómez-López and
  • Fátima Al-Shahrour

13 September 2019

In silico drug prescription tools for precision cancer medicine can match molecular alterations with tailored candidate treatments. These methodologies require large and well-annotated datasets to systematically evaluate their performance, but this i...

  • Article
  • Open Access
27 Citations
5,747 Views
17 Pages

CRISPR Loss-of-Function Screen Identifies the Hippo Signaling Pathway as the Mediator of Regorafenib Efficacy in Hepatocellular Carcinoma

  • Shigeki Suemura,
  • Takahiro Kodama,
  • Yuta Myojin,
  • Ryoko Yamada,
  • Minoru Shigekawa,
  • Hayato Hikita,
  • Ryotaro Sakamori,
  • Tomohide Tatsumi and
  • Tetsuo Takehara

13 September 2019

Regorafenib is used for hepatocellular carcinoma (HCC), but its response does not last long, partly due to chemoresistance acquisition. We performed a clustered regularly interspaced short palindromic repeats (CRISPR)-based loss-of-function genetic s...

  • Article
  • Open Access
23 Citations
5,143 Views
19 Pages

HSF1 Regulates Mevalonate and Cholesterol Biosynthesis Pathways

  • Hyeji Kang,
  • Taerim Oh,
  • Young Yil Bahk,
  • Geon-Hee Kim,
  • Sang-Yeon Kan,
  • Dong Hoon Shin,
  • Ji Hyung Kim and
  • Ji-Hong Lim

13 September 2019

Heat shock factor 1 (HSF1) is an essential transcription factor in cellular adaptation to various stresses such as heat, proteotoxic stress, metabolic stress, reactive oxygen species, and heavy metals. HSF1 promotes cancer development and progression...

  • Article
  • Open Access
29 Citations
5,930 Views
16 Pages

Next-Generation Sequencing Improves Diagnosis, Prognosis and Clinical Management of Myeloid Neoplasms

  • Diego Carbonell,
  • Julia Suárez-González,
  • María Chicano,
  • Cristina Andrés-Zayas,
  • Juan Carlos Triviño,
  • Gabriela Rodríguez-Macías,
  • Mariana Bastos-Oreiro,
  • Patricia Font,
  • Mónica Ballesteros and
  • Carolina Martínez-Laperche
  • + 6 authors

13 September 2019

Molecular diagnosis of myeloid neoplasms (MN) is based on the detection of multiple genetic alterations using various techniques. Next-generation sequencing (NGS) has been proved as a useful method for analyzing many genes simultaneously. In this con...

  • Article
  • Open Access
29 Citations
4,101 Views
10 Pages

13 September 2019

Background: Circulating tumor cells (CTC), androgen receptor full-length (AR-FL), and androgen receptor splice variant 7 (AR-V7) are prognostic in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC). AR-V7 seems to predict res...

  • Article
  • Open Access
19 Citations
3,828 Views
16 Pages

Matryoshka-Type Liposomes Offer the Improved Delivery of Temoporfin to Tumor Spheroids

  • Ilya Yakavets,
  • Marie Millard,
  • Laureline Lamy,
  • Aurelie Francois,
  • Dietrich Scheglmann,
  • Arno Wiehe,
  • Henri-Pierre Lassalle,
  • Vladimir Zorin and
  • Lina Bezdetnaya

13 September 2019

The balance between the amount of drug delivered to tumor tissue and the homogeneity of its distribution is a challenge in the efficient delivery of photosensitizers (PSs) in photodynamic therapy (PDT) of cancer. To date, many efforts have been made...

  • Article
  • Open Access
6 Citations
3,328 Views
20 Pages

Estrogens Counteract Platinum-Chemosensitivity by Modifying the Subcellular Localization of MDM4

  • Rossella Lucà,
  • Giorgia di Blasio,
  • Daniela Gallo,
  • Valentina Monteleone,
  • Isabella Manni,
  • Laura Fici,
  • Marianna Buttarelli,
  • Germana Ciolli,
  • Marsha Pellegrino and
  • Fabiola Moretti
  • + 9 authors

12 September 2019

Estrogen activity towards cancer-related pathways can impact therapeutic intervention. Recent omics data suggest possible crosstalk between estrogens/gender and MDM4, a key regulator of p53. Since MDM4 can either promote cell transformation or enhanc...

  • Feature Paper
  • Article
  • Open Access
58 Citations
5,283 Views
15 Pages

Human Ovarian Cancer Tissue Exhibits Increase of Mitochondrial Biogenesis and Cristae Remodeling

  • Anna Signorile,
  • Domenico De Rasmo,
  • Antonella Cormio,
  • Clara Musicco,
  • Roberta Rossi,
  • Francesco Fortarezza,
  • Luigi Leonardo Palese,
  • Vera Loizzi,
  • Leonardo Resta and
  • Gennaro Cormio
  • + 6 authors

12 September 2019

Ovarian cancer (OC) is the most lethal gynecologic cancer characterized by an elevated apoptosis resistance that, potentially, leads to chemo-resistance in the recurrent disease. Mitochondrial oxidative phosphorylation was found altered in OC, and mi...

  • Review
  • Open Access
10 Citations
4,763 Views
18 Pages

12 September 2019

Estrogens are major regulators of the mammary gland development, notably during puberty, via estrogen receptor (ER) activation, leading to the proliferation and differentiation of mammary cells. In addition to estrogens, the bone morphogenetic protei...

  • Article
  • Open Access
28 Citations
8,462 Views
21 Pages

Growth Hormone Upregulates Melanocyte-Inducing Transcription Factor Expression and Activity via JAK2-STAT5 and SRC Signaling in GH Receptor-Positive Human Melanoma

  • Reetobrata Basu,
  • Prateek Kulkarni,
  • Yanrong Qian,
  • Christopher Walsh,
  • Pranay Arora,
  • Emily Davis,
  • Silvana Duran-Ortiz,
  • Kevin Funk,
  • Diego Ibarra and
  • John J. Kopchick
  • + 7 authors

12 September 2019

Growth hormone (GH) facilitates therapy resistance in the cancers of breast, colon, endometrium, and melanoma. The GH-stimulated pathways responsible for this resistance were identified as suppression of apoptosis, induction of epithelial-to-mesenchy...

  • Article
  • Open Access
19 Citations
5,118 Views
16 Pages

CYP2D6 Genotype Predicts Plasma Concentrations of Tamoxifen Metabolites in Ethiopian Breast Cancer Patients

  • Jemal Hussien Ahmed,
  • Eyasu Makonnen,
  • Alan Fotoohi,
  • Abraham Aseffa,
  • Rawleigh Howe and
  • Eleni Aklillu

12 September 2019

Tamoxifen displays wide inter-individual variability (IIV) in its pharmacokinetics and treatment outcome. Data on tamoxifen pharmacokinetics and pharmacogenetics from black African breast cancer patient populations is lacking. We investigated the pha...

of 4

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
Cancers - ISSN 2072-6694